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Abstract 
 In order to safely and efficiently perform endovascular revascularization  
procedures among acute ischemic stroke (AIS) patients, general anesthesia or sedation is  
often required. However, anesthesia management during these procedures varies  
significantly worldwide and the procedural logistics have not been established yet. At  
some institutions AIS patients are intubated and paralyzed, while at other facilities, there  
is no routine protocol. In 2011 the University Hospital used “action nurses” (critical care  
float pool nurses) to provide pharmacological paralysis with sedation for intubated AIS  
patients under direct supervision of the neurointerventionalist. However, clinical 
outcomes among AIS patients undergoing endovascular procedures were poor. Exclusive  
utilization of the anesthesia team services for this patient population regardless of the  
anesthesia management modality chosen (sedation vs. general anesthesia) was introduced  
in November 2012. Implementation of this project helped to improve functional  
outcomes (as measured by a modified Rankin scale) among AIS patients undergoing  
endovascular revascularization therapy by 26.5% at 30-days follow up as compared to  
previous.  
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Introduction 
Background Knowledge 
 Stroke continues to be the leading cause of death and disability in the United  
States. Annually, approximately 800, 000 people experience a new or recurrent stroke  
with an estimated mortality rate of 53%-92% (Arnaout et al., 2012). Until recently, the  
only available treatment choice for acute ischemic stroke (AIS) has been intravenous (IV)  
tissue-type plasminogen activator (tPA) administration. Lately, new endovascular  
treatment options for AIS are evolving. Among them are intra-arterial (IA) thrombolysis  
with tPA and endovascular mechanical thrombectomy.  
Endovascular treatment options for AIS are among the least common procedures  
that neurointerventionalists perform, with approximately eight procedures per year per  
stroke center (Meyers et al., 2011).  Intra-arterial tPA administration continues to be an  
off-label procedure that must be delivered within six hours of symptoms onset. Moreover,  
it is associated with serious complications, such as intracranial hemorrhage and ischemic  
complications. Recently, there is an explosion of studies analyzing mechanical devices,  
that can be used beyond the six hour window (≤ 8 hours for anterior circulation vs.  ≤ 24  
hours for posterior circulation strokes) and promise improved patient outcomes (Soize et  
al., 2012). 
As study of treatment options for AIS patients expands, it is important to evaluate  
the management of these patients during endovascular revascularization procedures. In  
order to safely perform these interventions, patients often require anesthesia or sedation;  
however, anesthesia management practices during intra-arterial revascularization  
procedures vary significantly. At some institutions, AIS patients are intubated and  
paralyzed, while at other facilities, there is no routine protocol (Nichols et al., 2010). 
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In most cases, the preference of the neurointerventionalist performing the procedure  
dictates the choice and this choice is usually based on his/her experience and comfort  
level (Abou-Chebl et al., 2010). There is a paucity of high-quality data in the medical and  
nursing literature regarding the most optimal anesthesia clinical practices that should be  
implemented during these procedures. 
Local Problem 
Endovascular revascularization procedures for AIS, especially off-label use of  
endovascular thrombolysis with tPA, continues to be rare and controversial due to the  
potential risk of intracranial hemorrhage and other procedure-related complications. At  
the same time, the logistics of the procedure delivery have not yet been established  
(Arnaout et al., 2012). The choice of conscious sedation versus general anesthesia (GA)  
must be considered carefully based on the knowledge of the procedure, the patient history,  
and limitations of each of the anesthesia techniques (Table 1). In some AIS patients,  
intubation is necessary due to severe agitation or for airway protection (Avitsian & Somal,  
2012). However, “the role of an anesthesiologist in acute ischemic stroke management  
extends far beyond providing an immobile patient to minimize fluoroscopic artifacts”  
(Avitsian & Somal, 2012, p. 524). Regardless of the choice of anesthesia technique, intra- 
procedural management of the patient’s hemodynamics (blood pressure, cardiac  
arrhythmias), airway and procedural complications by the neuroanesthesia expert could  
be vital to the AIS patient’s outcomes and survival.  
 At the author’s institution, if an endovascular revascularization procedure is 
recommended for AIS, the patient is intubated in the Emergency Department (ED) and 
transferred to the Interventional Radiology (IR) suite. Pharmacological paralysis  
combined with sedation is provided by an ER or ICU float pool RN (“action nurse’) and  
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supervised by the neurointerventionalist. Less frequently, general anesthesia is provided  
by an anesthesiologist.  
 Each of the anesthesia management techniques has its advantages and limitations  
Limitations specific to this facility’s protocol include using an “action nurse,” who is not  
an expert in handling this level of responsibility. Frequently, an action nurse has never  
participated in this type of procedure before; therefore, s/he might not be familiar with  
the routine and expectations of the interventional neuroradiologist performing the  
intervention. As a result, the nurse might not be comfortable with communicating  
unexpected procedure-specific complications (i.e. hemodynamic changes) with the  
neurointerventionalist effectively and in a timely manner. Moreover, s/he might not be  
aware of the potential complications or  how to manage them, especially since these 
endovascular interventions are uncommon and there are no clear guidelines for  
hemodynamic management of AIS patients. Last year, there were nine endovascular  
revascularization procedures performed at the author’s facility. This number is close to  
the national average.  
 Another concern is that ER/ICU float nurses are not always experts in managing  
optimal blood pressure among AIS patients, and appropriate management of blood 
pressure is crucial among this patient population. Blood pressure should not be higher  
than 185/105 with thrombolytic therapy (Shaikh, 2010). At the same time, “the rapid  
lowering of blood pressure could be detrimental” (Lee et al., 2004, p. S15). According to  
Leonardi-Bee et al. (2002), “for every 10 mmHg of systolic blood pressure below 150  
mmHg, the risk of early death increased by 3.6% and the risk of late death and  
dependency increased by 17.9%” (Grise & Adeoye, 2012, p. 133). On the other hand,  
 “for every 10 mmHg increase in systolic blood pressure above 150 mmHg the risk of  
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early death increased by 3.8%” (Grise & Adeoye, 2012, p. 133). The target pressure (20- 
30% above the patient’s baseline on admission to the emergency department) should be  
achieved gradually to maintain cerebral perfusion pressure (Lee et al., 2004). Therefore,  
continuous monitoring of blood pressure with an arterial line is ideal. However, in cases  
of sedation provided by an RN at the author’s facility, a radial arterial line is usually  
absent. Instead a manual blood pressure measurement is taken every five minutes. 
While the neurointerventionalist is fully focused on a time-sensitive procedure  
(“time is brain”), it would be helpful and safer for the patient to have an anesthesia expert  
be responsible for hemodynamic management rather than a sedation RN, who has to rely  
on verbal orders provided by the neurointerventionalist and does not always have up to  
date knowledge, especially when considering a paucity of data supporting blood pressure  
management in the early stages of AIS (Grise & Adeoye, 2012). Although endovascular  
revascularization procedures among AIS patients are still rare, there are other elective  
and emergency neuroendovascular procedures, such as intracranial aneurysm and  
arteriovenous malformation embolization, pre-operative embolization of vascular tumors,  
angioplasty and stenting of the intracranial vessels, that neurointerventionalists perform.  
All of the above neuroendovascular interventions, are always performed with the  
involvement of the anesthesia team at the author’s institution. Moreover, the  
anesthesiologists/nurse anesthetists at the author’s facility are responsible for managing  
the patients undergoing open vascular and neurovascular surgeries. Therefore, with no  
doubt the anesthesia team has a higher expertise in the anesthesia management of AIS  
patient population when compared to sedation nurses. 
The above issue also applies to the management of cardiovascular complication                                                                                                                             
encountered during an endovascular intervention, such as cardiac arrhythmias, cardiac  
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ischemia, bradycardia and heart failure. “Myocardial injury can occur immediately  
preceding AIS (eg, causing cardioembolism), concurrent with AIS (eg, myocardial  
infarction), or as a result of sympathetic relative hyperactivity and catecholamine release  
caused by AIS” (Coplin, 2012, p. 552). 
 Moreover, the AIS patient population itself is a challenge as far as hemodynamic  
management is concerned. Most of these patients are elderly and have multiple medical 
comorbidities, such as atrial fibrillation, hypertension, hyperlipidemia, coronary artery  
disease, heart failure, diabetes mellitus and obesity (Coplin, 2012). The most frequent  
etiology of cardioembolic cerebral infarction includes “atrial fibrillation, recent 
myocardial infarction, mechanical prosthetic valve, dilated cardiomyopathy and mitral  
rheumatic stenosis” (Arboix, A. & Alio, J., 2012, p. 54). “In adults over 55 years of age,  
the lifetime risk for stroke is greater than 1 in 6” (Roger, V.L. et al., 2012, p. e101). In  
addition, there is often a scarcity of knowledge of the patient’s history and fasting status,  
as these procedures are typically performed on an emergent basis (Young, 2007). These  
factors raise the level of risk associated with anesthesia and justify the presence of an  
anesthesiologist during endovascular procedures. Due to the above cardiac risks among  
AIS patients, their fluid and electrolyte balance should be closely monitored during the  
procedure, especially in patients with  a history of heart failure, fluid overload should be  
avoided. Because of their risk factors for coronary artery disease and stroke, a large  
percentage of these patients are managed at baseline with either single (aspirin) or dual  
antiplatelet prophylactic therapy (aspirin and plavix). A combined antiplatelet therapy  
with plavix and aspirin prior to the onset of AIS, increases significantly these patients’  
risk for a symptomatic intracranial hemorrhage, especially if on the top of that they also                                      
receive either IV and/or intra-arterial tPA therapy for AIS treatment (Tarlov et al., 2012).  
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There is also evidence available that shows a correlation between hyperglycemia during  
the acute phase of stroke and poor outcome with endovascular revascularization therapy  
(Tarlov et al., 2012). Therefore, hyperglycemia should be avoided and blood glucose  
level checked routinely during the acute phase of ischemic stroke. The above points are 
additional reasons to have a member of the anesthesia or neurocritical care team to  
monitor and manage these patients during the endovascular revascularization procedures. 
 Probably the strongest contra-argument against using sedation nurses during AIS  
endovascular procedures is their ability to manage the airway in non-intubated patients.  
Despite the findings of a few retrospective studies revealing possible worse outcomes  
with intubation during AIS endovascular revascularization procedures, intubation is  
unavoidable in specific clinical situations, particularly when the patient is agitated or  
unable to protect his/her airway. Adding a prolonged supine position and unknown  
fasting status of these patients increases the risk of pulmonary aspiration and hypoxia  
during the procedures with conscious sedation. Sometimes, emergent intra-procedural 
intubation is required due to the patient’s agitation, oversedation, or decline in the  
patient’s neurological status (Froehler et al., 2012). The sedation provided by sedation  
nurses and supervised by a neurointerventionalist, usually is light or moderate, and not  
deep sedation; unless, the patient is intubated and pharmacologically paralyzed. Deep  
sedation without intubation requires skills in advanced airway management and  
intubation. Neither the sedation nurse nor neuroproceduralist, is adept at rapid intubation  
as it is outside their typical practice focus. “Emergent conversion to GA during the  
endovascular procedure could result in patient injury from endovascular devices, hypoxia,  
or aspiration and necessitates the presence of a practitioner skilled in endotracheal  
intubation” (McDonagh et al., 2010, p. 3). 
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 In addition, a remote location of the Interventional Radiology suite, far from the  
main operating rooms, decreases the chances of a rapid response from the anesthesia  
team, especially when the procedure takes place during off hours (Froehler et al., 2012).  
Therefore, having the anesthesia team from the beginning of the endovascular procedure  
provides the patient and neurointerventionalist with the most optimal scenario, since the  
anesthesiologist can facilitate different levels of sedation and emergently intubate the  
patient, if necessary, without significantly delaying the opening of the occluded vessel.  
Having anesthesia experience and frequent practice in airway management clinical  
scenarios translates into faster revascularization treatment.  
 Making a decision regarding a request for anesthesia vs. a critical care float pool  
nurse takes additional time and “time is brain.” Sometimes, while waiting for an action  
nurse, the patient’s condition deteriorates, and an anesthesiologist is required to provide  
general anesthesia for this patient. Additional waiting lowers the patient’s chances for a  
good outcome (Meyers et al., 2009).  
 Introduction of this protocol made a decision regarding the choice of anesthesia  
management easier and eliminated additional steps in the process allowing the institution  
to improve performance measures (eg. time from arrival to femoral puncture for intra- 
arterial thrombolytic infusion and/or mechanical recanalization therapy). Currently, a  
request for the anesthesia team is placed as soon as the Emergency Department knows  
about potential arrival of the patient with AIS. 
Intended Improvement/Purpose of Change     
 The proposed change was the creation of a standard anesthesia management  
protocol for endovascular revascularization procedures among acute ischemic stroke  
patients that would always be provided by anesthesia services, but the type of anesthesia  
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would be chosen based on the clinical presentation. This required classifying a  
revascularization procedure as a neurologic emergency; therefore, the anesthesia team  
had to be available within 15 minutes from the time request had been made. 
 By December 1, 2013 the University Hospital improved functional outcomes  
(as measured by a modified Rankin scale) among acute ischemic stroke patients  
undergoing endovascular revascularization procedures by 26.5% at 30-days follow up as  
compared to the outcomes from 2011. The chosen objective was as follows: 
Creation of a standard anesthesia management protocol (monitored anesthesia 
            care vs. general anesthesia) for endovascular revascularization procedures among  
 acute ischemic stroke patients, provided exclusively by a member of the   
 anesthesia team. Anesthesia choice is based on a clinical presentation and  
 determined by collaboration between the stroke neurologist,  
 neurointerventionalist and anesthesiologist. 
These were two available options: 
Option #1 
Status quo: continue current process. Unfortunately, the clinical outcomes of AIS  
patients who have undergone endovascular revascularization procedures at the University  
Hospital are poor, their length of stay is prolonged and the healthcare cost associated with 
providing care to these patients is high. 
Option #2 
Implement a standard anesthesia management protocol during endovascular  
revascularization procedures. This process would help to start these interventions in a  
timely-manner (“time is brain”), aim to improve the functional outcomes among AIS  
patients, decrease the length of hospital stay and lower the healthcare costs.         
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Review of the Evidence 
 Findings from a few recent retrospective studies have suggested a correlation  
between general anesthesia (GA) and poor clinical outcomes among AIS patients  
undergoing endovascular revascularization therapy (Davis et al., 2012). This data,  
however, must be analyzed carefully as patients with more severe stroke (higher National  
Institutes of Health Stroke Scale [NIHSS] score) were more likely to be included in the  
general anesthesia group (Nichols et al., 2010). Also, while reviewing these findings, one  
can notice a chronological trend toward more detailed description of the anesthesia  
management logistics. The newer studies, although still retrospective, provide a clear  
definition of conscious sedation, including the type of medications used and their dosages,  
as well as specify who administered conscious sedation (anesthesia team  vs. non- 
anesthesiologist). So far, however, there is no research available analyzing the outcomes  
between two groups of AIS patients; those who have been managed by the anesthesia  
team vs. those who have been managed by the non-anesthesiologist (eg. sedation RN  
with supervision of a neurointerventionalist). 
 In a restrospective study by Jumaa et al. (2010), the authors compared the  
outcomes of endovascular revascularization therapy in two groups of consecutive AIS  
patients. One group underwent the above procedure with conscious sedation without  
intubation (non-intubated state-NIS), while the other group of patients was intubated  
(intubated state-IS) with general anesthesia. The authors found that length of stay in the  
intensive care unit was longer for the general anesthesia group (6.5 vs. 3.2 days,  
p=0.0008). Moreover, the rate of intraprocedural complications was lower among  
nonintubated patients as compared to the intubated group (6% vs. 15% respectively,  
p= 0.13); however, the difference was not statistically significant. Also, there were no  
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significant discrepancies found in clinical outcomes and final infarct volumes on follow  
up imaging between the two anesthesia management techniques. Regardless of the  
anesthesia management modality (intubated state vs. nonintubated state), all procedures  
in this study were performed with the involvement of an anesthesiologist.  
Another retrospective study by Davis et al. (2012) attempted to identify possible  
causes of poor outcome among AIS patients who had undergone endovascular  
revascularization procedure with general anesthesia vs. local anesthesia/sedation. The  
authors reviewed the medical records of 129 patients, who had received treatment  
between January 2003 and September 2009. The study group included 96 out of 129  
patients for whom 3 months post-stroke outcome scores measured with the modified  
Rankin Scale (mRS) were available. The choice of anesthesia modality was a result of  
collaboration between the neurologist, radiologist and anesthesiologist. In cases of local  
anesthesia, light conscious sedation with IV midazolam and fentanyl was provided by the  
stroke neurologist. As soon as deep sedation was needed, the patient was intubated and  
light general anesthesia was delivered by an anesthesiologist. Some of the reasons for  
intubation were pre-intervention aspiration, airway obstruction, or worsening in the  
patient’s level of consciousness. 
 In addition to anesthetic technique, Davis et al. (2012) analyzed other functional  
outcome predicting variables, such as patient’s age, comorbidities, the baseline stroke  
severity (NIHSS score), blood pressure, blood glucose concentration, and time interval  
from stroke onset to endovascular treatment. At three months post-stroke follow up,  
twenty two patients (23%) had no or minimal neurologic deficits (mRS 0-1), 37 patients  
(39%) were functionally independent (mRS 0-2), and 25 patients (26%) died. Mortality 
rate was higher in the general anesthesia group. After adjusting for baseline stroke  
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severity, sedation and no incidence of hypotension (blood pressure ≤ 140 mmHg) were  
predictors of a good functional outcome. The authors reported a good functional outcome  
in fifteen percent of patients managed with general anesthesia, as opposed to sixty  
percent of patients who were managed with sedation (p < 0.001). 
 In a prospective, small size sample (36 patients) study by Soize et al. (2012), the  
investigators attempted to analyze the feasibility, safety and efficacy of endovascular  
mechanical thrombectomy with a Solitaire FR device under conscious sedation  among  
AIS patients, who presented with NIHSS score ≥ 8. The study sample included  
consecutive patients with AIS caused by occlusion of a large artery (≤ 6 hours for  
anterior and ≤ 24 hours for posterior circulation). The primary outcomes measured at 3- 
months follow up were mortality rate and functional outcome. Twenty two patients  
(61.1%) presented at 3-months follow up with good functional outcomes and ten patients  
(27.8%) had a poor outcome or died. Successful revascularization was accomplished in  
twenty eight (77.8%) patients. The anesthesia team was used only in “severe cases,” the  
definition of which was not provided; whereas conscious sedation with IV midazolam  
was administered by the stroke neurologist.   
McDonagh et al. (2010) studied anesthesia preference for endovascular  
revascularization therapy among AIS patients by surveying members of the Society of  
Vascular and Interventional Neurology (SVIN) with a 12-question review. Response  
rate was high at 72% (n= 49/68). As reported by survey respondents, the most frequently 
used anesthesia type was general anesthesia (GA), followed by conscious sedation (nurse 
administered), then monitored anesthesia care (MAC) administered by the anesthesia  
team, and finally local analgesia alone. Preference for GA was associated with a type of  
endovascular procedure. Mechanical thrombectomy was most frequently associated with  
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a request for GA (55% of respondents). General anesthesia was a preferred practice for  
patients with a NIHSS score >15 (53% of respondents) and patients with brainstem stroke  
(51% of respondents). More than half (50.3%) of respondents felt strongly than any  
mechanical manipulation, such as angioplasty and/or stenting required GA.  Eliminating  
patient’s movement, perceived procedural safety and improved procedural efficacy were  
additional reasons for choosing GA. Limitations of GA included: time delay, cerebral  
ischemia as a result of hypoperfusion, and lack of adequate anesthesia workforce.  
Nichols and colleagues (2010) retrospectively analyzed procedural sedation  
among patients from the Interventional Management of Stroke (IMS) II trial. Patients  
with moderate to severe (NIHSS >10) anterior circulation strokes, who underwent  
conventional cerebral angiogram and/or intra-arterial revascularization were included in  
this study. While conducting IMS pilot trials I and II, the authors noticed a high level of  
variation in use of peri-procedural sedation. In addition, they observed an absence of a  
standard anesthesia/sedation protocol for AIS endovascular procedures. Therefore, the  
emphasis of this retrospective study was the level of sedation used during the  
endovascular procedures, its association with patient outcomes and factors that  
influenced the level of sedation. Out of 75 patients who met the inclusion criteria, 40  
 (53%) received no sedation and 17 (23%) were pharmacologically paralyzed. A higher  
sedation level was used for patients with aphasia, internal carotid artery occlusion and in  
patients with longer procedure times. Baseline NIHSS score varied widely between the 
different levels of sedation (p= 0.03). Lower levels of sedation and male gender were  
correlated with good clinical outcome. The highest level of sedation, including  
pharmacological paralysis, was an independent predictor of death. Mild or no sedation,  
and no internal carotid artery occlusion were predictors of successful reperfusion. The  
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study found a significantly higher level of infection (pneumonia and/or sepsis) in patients  
who received heavy sedation (p= 0.02). High sedation level remained a predictor of poor  
clinical outcome and death even after baseline NIHSS score was accounted for in  
multivariable analysis. Besides a retrospective design and small sample size, Nichols and  
colleagues (2010) were not able to precisely identify the types of anesthesia medications  
used, the duration of the treatment, the times of administration in relation to the  
angiographic procedure, and the route of administration. The authors did not specify who  
provided the anesthesia management during the procedure. 
Abou-Chebl and colleagues (2010) sought to examine the relationship between  
the type of anesthesia used during endovascular therapy for AIS involving anterior  
circulation, and patient safety and outcomes. The authors studied retrospectively a group  
of 980 patients at twelve stroke centers in the United States, who underwent endovascular  
therapy for AIS between 2005-2009. A total of 428 (44%) patients were placed under GA  
before the procedure started. The general anesthesia group was more likely to have distal  
carotid occlusion (25% vs. 15%, p <0.01) and higher NIHSS scores on admission (17±5  
vs. 16±6, p<0.01) compared to the conscious sedation group. Even after the study results  
were adjusted for age, initial NIHSS score, time to femoral artery puncture, time to vessel  
opening, recanalization outcome, and intracerebral bleeding complication, patients placed  
under GA were at significantly higher risk of a poor outcome. This study concluded that  
conscious sedation seemed to be as safe as GA with respect to the procedural  
complication of intracranial hemorrhage (Abou-Chebl et al., 2010). However, not  
controlling for comorbidities, patient clinical status and endovascular techniques, are  
some of the limitations of the study. Furthermore, the investigators did not address the  
issue of emergency intubation since they could not differentiate between the group of  
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patients who were intubated before the procedure and those who were intubated  
emergently during the procedure. A clear definition of conscious sedation and who  
managed it was not provided in the study methodology.  
 In the most recent study by Li et al. (2013), the researchers were attempting to  
analyze the impact of the anesthesia technique on mortality rate among AIS undergoing  
endovascular revascularization therapy between December 2006 and October 2012. In  
their retrospective investigation they compared two groups of patients: general anesthesia  
group (N= 35) vs. conscious sedation group (N= 74). They found that general anesthesia  
and post-procedural hyperglycemia (blood glucose > 200 mg/dL) were the most  
important predictors of mortality (mortality rate 40% vs. 22% when comparing general  
anesthesia vs. conscious sedation group, p= 0.045). The time from AIS symptoms onset  
to recanalization and the length of endovascular revascularization procedure were longer  
in the general anesthesia group. There were no statistically significant differences  
between general anesthesia and conscious sedation groups as far as procedure-related  
complications (p= 0.997) and the patients’ functional outcome at discharge (p= 0.631).  
However, a 90-day clinical follow up could provide more information regarding a long- 
term outcomes. Although the rate of pneumonia was higher in general anesthesia group  
(21% vs. 16% in conscious sedation group), it had not been associated with a higher  
morbidity or mortality based on this study findings. Only patients treated with Merci  
retriever and Penumbra thrombectomy devices were included in this study. The  
procedures performed with the latest generation of stent-retriever technology, which are  
superior in performance when compared to the old generation devices (eg. Merci  
retriever), were not included in this study. Before 2011, general anesthesia was used at  
this institution routinely for all patients undergoing endovascular treatment for AIS. It has  
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changed after 2011as neurointerventionalists had become more familiar and comfortable  
with using conscious sedation for AIS patients during endovascular therapy procedures.  
The retrospective study design, lack of randomization and small sample size are the  
major limitations of this study. 
Conceptual/Theoretical Framework 
 The healthcare environment is a chaotic, complex adaptive system, made up of  
multiple diverse, but interconnected elements. Therefore, a Chaos Leadership Theory was  
chosen as a conceptual framework to help guide the author of this project in achieving set  
goals. 
 The first step to success according to this theory is a leadership style that “focuses  
less on prediction and control and more on fostering relationships and creating conditions  
in which complex adaptive systems can evolve to produce creative outcomes” (Burns, J.,  
2001, p. 474). A complexity-based leadership approach is found on the assumption that  
employees of a healthcare organization have the ability to self-organize and to produce  
desired outcomes despite providing an impression of chaos. The relationships among the  
employees are more important than the employees themselves in order to achieve  
expected results. The author of this project created a general vision of the process change  
while providing reasons for it, without planning every detail of the change. According to  
complexity theory, leaders who raise questions that have no obvious answers (like the  
one in this project: What is better, general anesthesia vs. sedation for endovascular  
revascularization procedures among AIS patients), create tension and anxiety, which may  
lead to increased creativity and innovation (Burns, 2001). Publishing a manuscript by the 
author on the same topic started a public discussion and motivated researchers and  
healthcare organizations to study this issue even further. 
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 According to complexity theory, “organizations that are learning should start  
small, experiment to find the small things that work, and then link the successful pieces  
together into more complex systems” (Burns, J., 2001. p. 479). The clinical outcome of  
an AIS patient, who undergoes endovascular revascularization therapy might be affected  
by a multitude of factors, type of anesthesia being just one of them. However, if we  
control for some of these confounding variables by providing the highest currently  
available standards of care (anesthesia team for all AIS patients regardless of the  
anesthesia management technique chosen), we will be able to establish procedural  
logistics sooner. 
Methods 
Ethical Issues 
 Claiming that nursing colleagues do not have enough skills and knowledge to  
provide procedural sedation to AIS patients during endovascular revascularization  
procedures was the main ethical dilemma that the author had to face as a result of this  
project implementation. It created some tension and animosity among staff nurses. On the  
other hand, it helped other nurses who shared the author’s point of view with their moral  
distress. According to complexity theory, however, whenever there is a controversy, it  
creates a tension that leads to increased creativity and self-organization. 
 A further ethical issue associated with this project pertained to allocation of  
resources. Reclassification of endovascular procedures for AIS as a neurological  
emergency takes the anesthesia team away from the patients who were scheduled for  
elective procedures. There were times that elective procedures had to be rescheduled and  
postponed. The question of who should explain the reason for procedure/surgery  
cancellation to the patients was also raised. However, maintaining the status quo also  
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produced an ethical dilemma. There is a close association between nursing goals and  
ethics. Underlying nursing practice is the intention to do good, avoid harm, commit to  
and protect the patient, and advance social policy for the greater good (Grace, 2009).  
Being inadequately skilled in an intervention (incompetence), such as providing  
anesthesia management to patients with AIS during endovascular revascularization  
procedures creates an ethical dilemma that is against the American Nurses Association  
(ANA) Code of Ethics (Grace, 2009). It violates the principles of fidelity, patient  
advocacy, and protection of the patient’s welfare, especially since this particular patient  
population is vulnerable and defenseless. 
 An additional ethical issue related to AIS revascularization therapy is that the  
procedures are costly (~$30,000-40,000),  not FDA approved (off-label intra-arterial tPA  
administration), and currently associated with a potential serious complications (eg.  
intracranial bleeding). At the same time, the presence of numerous variables affecting the  
outcome of AIS (time to treatment, thrombus type, location and size of thrombus,  
proceduralist’s skills, and the individual patient’s characteristics, such as collateral  
circulation, comorbidities, age) makes the research investigation more difficult. These  
procedures are still rare due to lack of sufficient infrastructure supporting the rapid triage  
and transport of patients with AIS to stroke centers (Blackham et al., 2012). Availability  
of additional and stronger scientific evidence in the future could lead us to conclude that  
AIS patients have been undergoing low efficacy procedures with risks outweighing the  
benefits, and the society has been exposed to wasteful spending (the justifiable  
distribution of resources theory).  
 A separate complex ethical concept associated with this problematic clinical  
practice is the issue of informed consent for an endovascular revascularization therapy.  
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As described previously, it can be overwhelming to healthcare experts to make a decision  
to proceed with an endovascular revascularization procedure for AIS treatment. However,  
it is even more challenging to explain this procedure to a lay person, especially when it  
has to be done urgently and via phone. In order to do it efficiently, “we need to  
understand the patient’s beliefs, values, and goals; the patient’s/family’s ability to process  
information; and psychological, physiological, or environmental factors that might  
interfere with or facilitate processing of information” (Grace, 2009, p. 84). As far as  
religious values discussion, a potential for blood transfusion option in case of a vessel  
rupture would have to be disclosed to Jehovah’s Witness patient/family when obtaining  
an informed consent. 
  Despite available treatment options for AIS, only 4.3% of AIS patients receive  
IV tPA within the narrow treatment window, and the percentage is even smaller in  
regards to intra-arterial treatment options (Jauch et al., 2013). The concept of distributive  
justice in relation to AIS medical management could be related to limited public and  
healthcare provider recognition of early stroke symptoms,  and limited access to stroke  
centers. One of the studies revealed a delay in initiation of endovascular therapy among  
patients who were transported from a community hospital, as opposed to those who were  
transferred directly to a comprehensive stroke center (El Khoury et al., 2012). 
Setting 
 The project implementation took place at the University Hospital, a major  
academic health center, which is an approximately 630-bed level I  trauma center for both  
adults and pediatric patients, and an advanced primary stroke center certified by the Joint  
Commission in July 2009. The facility provides 24/7 access to the Interventional  
Neuroradiology suite, where endovascular revascularization procedures for AIS can be  
ACUTE ISCHEMIC STROKE                                                                                         21 
performed. It has two neurointerventionalists on staff, who rotate taking calls. One of  
them obtained training in Diagnostic and Interventional Neuroradiology; the other is a  
neurosurgeon with additional preparation in minimally invasive neuroendovascular  
procedures. This facility has been characterized by satisfactory nursing staffing ratios  
protected by union rules. The institution’s radiology nurses and angiography  
technologists take call during off-shifts and are available continuously, if needed for a  
variety of emergency cases.  At the same time, there is a shortage of anesthesiologists,  
which initially posed a threat to a success of this project. 
 There were multiple stakeholders involved in this project including the  
Emergency Department, Neurology, Radiology (CT, MRI), Interventional  
Neuroradiology, Anesthesia, and the Quality Management Departments. These are  
separate and semi-autonomous work units that are loosely coupled and specialize in  
different areas of care delivery. Organizational loose coupling can limit the flow of  
information and make it difficult to coordinate services for AIS patients (Pinelle &  
Gutwin, 2006). For this reason, the facility organized the stroke committee with regular  
meetings taking place every three months and led by the Stroke Program Director for  
periodic evaluation of care provided to AIS patients and their outcomes. During each  
meeting the hospital stroke committee made recommendations for future improvement of  
processes based on the available outcomes of AIS patients. 
 Planning for this project took place at the same time as the hospital’s submission 
processes for Magnet status. Therefore, the timing for it could not have been better since  
every administrator, manager and staff nurse was actively involved in a variety of the  
evidence-based projects. This project and a manuscript published on the same topic were  
also used to help the facility to obtain Magnet recognition. 
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Planning the Intervention  
 In 2011, nine endovascular revascularization procedures for AIS were performed  
at the author's institution. Only one of these patients had an improvement in functional  
outcomes. The statistics nationwide are not more encouraging, and the average cost of the  
endovascular procedure is high (approximately $30,000-40,000), not including the costs  
of the hospital stay. Moreover, neither IV tPA, nor endovascular therapy have been found  
to reduce mortality from stroke (Lackland et al., 2014). After reviewing available  
literature, there was not enough strong evidence to support one method of anesthesia  
management vs. another. There are few restrospective studies, which compare the  
outcomes of endovascular revascularization therapy based on the method of anesthesia  
management. Current evidence is not sufficient to guide the choice of anesthesia for  
endovascular revascularization interventions in patients with AIS (Flexman, Donovan &  
Gelb, 2013).  
 In one of the recent studies, Jumaa et al. (2010) found that length of stay in the  
intensive care unit was longer in the intubated patient group (6.5 vs. 3.2 days, p= 0.0008).  
Moreover, the rate of intraprocedural complications was lower among nonintubated  
patients as compared to the intubated group (6% vs. 15% respectively); however, the  
difference was not statistically significant  (p= 0.13). Also, there were no significant  
discrepancies found in clinical outcomes and final infarct volumes on follow up imaging 
between the two anesthesia management techniques. Worth noticing is the fact that all  
procedures in this study were performed with the involvement of an anesthesiologist. 
 If prospective randomized trials continue to support moderate sedation as the  
anesthesia of choice for endovascular procedures, the current use of “action nurses” at the 
author’s institution would remain problematic as they are not the experts in airway  
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management and hemodynamic stabilization. These situations require the presence of an  
expert anesthesiologist for airway protection, emergent intubation, optimal hemodynamic  
control, and prompt management of intra-procedural adverse events, such as reperfusion  
injury, acute cerebral ischemia, ventricular arrhythmias, bradycardia, myocardial  
ischemia, and pulmonary aspiration (Lee et al., 2004).   
 Although anesthesia resources are scarce at the author’s institution, AIS patients  
deserve the same attention as trauma surgery patients do, since delay in intervention  
could result in the patient’s death or severe disability. Therefore, the same process for the  
anesthesia team request should apply to both trauma surgery as well as acute ischemic  
stroke, even if elective surgeries/procedures have to be postponed.  
Based on above market analysis, outcome results of the endovascular  
revascularization procedures among AIS patients at the author’s institution,  and a review  
of the related literature, there was an obvious need for a change and process improvement.  
The proposed change was the exclusive utilization of anesthesia services for  
endovascular revascularization procedures among AIS patients regardless of the used  
anesthesia management modality (sedation vs. general anesthesia). Anesthesia choice  
would be based on clinical presentation and determined by collaboration between the  
stroke neurologist, neurointerventionalist and anesthesiologist. Once endovascular  
revascularization was recommended, the anesthesia and Interventional Radiology staff  
would be notified, so they could start preparation for the procedure.  
 The leadership of this project had hopes that implementation of this new  
anesthesia protocol would improve the outcomes of the AIS patients undergoing  
endovascular treatment, decrease the length of hospital stay, and result in financial  
savings to the facility as illustrated in Appendix B. The costs associated with the proposed  
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project were related solely to anesthesia professional and technical fees. These  
expenses vary depending on the type of anesthesia modality used (monitored anesthesia  
care vs. general anesthesia). Any surgery/procedure over four hours, where a general  
anesthetic is used costs approximately $7,300; whereas, monitored anesthesia care costs  
are approximately $3,530 for the same length of time. Placement of an arterial line  
(recommended for this procedure) or central line during a procedure also raises costs. In  
comparison, costs for one day of stay in a Neurosurgical Intensive Care Unit (room rate)  
are approximately $17,000.  Therefore, if the length of stay in the Neurosurgical  
Intensive Care Unit was reduced by one day only, the cost of anesthesia would be  
covered, and the hospital could even save money ($17,000- $7,300= $9,700 per  
procedure). Multiplying $9,700 times 9 (number of endovascular revascularization  
procedures performed at the University Hospital in 2011), would bring $87,300 in  
savings annually.  
 The process of a 30-day follow up for the functional outcome evaluation among  
AIS patients and monitoring of endovascular revascularization procedures complications  
has not changed as a result of this project implementation. A follow up has been  
performed by the Neurology service in collaboration with the Quality Management  
department. Therefore, there was no change to this process and no additional costs  
associated with it. The project implementation took approximately one year (November 1,  
2012 to December 1, 2013). A detailed work breakdown structure is presented in  
Appendix C. The evaluation process of the project still takes place, and improvements are  
being made. It is a constant work in progress. 
Implementation of the Project 
 The implementation of the above process change started on November 1, 2012,  
ACUTE ISCHEMIC STROKE                                                                                         25 
after approval by the hospital administration. Before its initiation, the project plan 
proposal was presented to all stakeholders (Interventional Neuroradiology faculty,  
Interventional Radiology management, Stroke Program Director, Chair of Anesthesia  
Department, Emergency Department management, Quality Management Department and  
Stroke Committee). Stroke Committee meetings were the main source of communication  
between all stakeholder. The patient’s follow up and outcome evaluation at 30 days 
(either in person or as a telephone interview) has been conducted by the Neurology  
service (similarly to 2011) and data for the study period between 11/01/2012 and  
11/01/2013 was presented to all stakeholders at the end of the project implementation  
(December 2013). 
 Project implementation was discussed at each Stroke Committee meeting (on  
average meets every three months). Suggestions from Stroke Committee members were 
carefully analyzed and if appropriate, adjustments to the project proposal were made. The  
Anesthesia Chair was updated at three month intervals (more often, if needed) regarding  
the project progress and anesthesia issues (i.e. anesthesia delays). The Interventional  
Neuroradiology Nurse Practitioner (NP) presented the project proposal and its 
implementation date to the  Interventional Radiology staff (nurses and techs). Before the  
project implementation, there were multiple presentations provided to the Emergency  
Department and critical care float pool nurses (“action nurses”), who were previously  
responsible for providing a sedation to already intubated and pharmacologically  
paralyzed AIS patients during their endovascaular stroke therapy. A detailed statement of  
work with scheduling plans (GANTT chart) can be found in Appendix C.  
Planning the Study of the Intervention 
 A neurologist, who is the Stroke Program Director, was the leader of this project.  
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An administrative nurse researcher, who is accountable for the Stroke Program Clinical  
Operations, was responsible for collecting and presenting a summary of all stroke  
(ischemic and hemorrhagic) performance measures and areas for improvement at each  
committee meeting. 
 To assess how effectively the intervention was implemented, the Neuroradiology  
NP was assigned to monitor the following performance measures: times of patients’  
admission to ED or stroke symptoms onset if inpatient, start and completion times of a  
CT Head and/or MRI Brain diagnostic studies, time to femoral artery puncture, and time  
to intra-arterial tPA administration and/or time of clot crossing with a mechanical  
thrombectomy device. These performance measures were not documented prior to this  
project implementation. 
 A Neurology resident was responsible for monitoring the AIS patients’ response  
to IV  tPA, intra-arterial tPA and /or mechanical thrombectomy, their clinical outcomes at  
30-days follow up either via phone or in person  (with the assessment of a modified  
Rankin scale), and complications (death, symptomatic intracranial hemorrhage or  
ischemic stroke). Although the author’s facility has the advanced primary stroke  
certification, the hospital is in the process of pursuing comprehensive stroke certification.  
Therefore, the hospital’s stroke committee decided to use comprehensive stroke measures  
to evaluate the clinical outcomes of AIS patients.  
 The baseline data prior to the project implementation is very raw (does not  
include a clinical outcome assessment with a modified Rankin scale) and is presented in 
Table 2. In comparison, the data for the study period between 01/01/2013 and 11/01/2013  
can be found in Table 3 and reveals higher (26.5%) than the anticipated 25%  
improvement in clinical outcomes at 30-day follow up among AIS patients undergoing  
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endovascular intervention after the project implementation. There was also decrease in  
mortality rate between 2011 and the time of project implementation (33.3 %  vs. 12.5%  
respectively). At 30-days post-stroke follow up, three patients (37.5%) were functionally  
independent (mRS ≤ 2). However, the number of AIS patient undergoing endovascular  
revascularization therapy has decreased from 9 patients in 2011 to 8 patients during study  
period. 
Methods of Evaluation 
 The primary outcome of this project implementation was the clinical results as  
measured with a modified Rankin scale at 30-days follow up. Neurology service  
performed the assessment either in-person or via phone among AIS patients who had  
undergone an endovascular revascularization therapy with intra-arterial tPA and/or  
mechanical thrombectomy with the assistance of the anesthesia team. 
 The following were the secondary outcomes: time from the patient’s hospital  
arrival to femoral puncture, time from hospital arrival to the first clot crossing with a  
mechanical thrombectomy device or intra-arterial tPA administration, incidence of  
serious complications (death, symptomatic intra-cranial hemorrhage, ischemic stroke),  
and cost of the hospitalization. The hospital’s billing department was not willing to  
provide the actual costs accrued during the patient’s admission for AIS; therefore, the  
cost was roughly estimated based on the length of the hospital stay. 
Analysis 
 Project implementation resulted in better than expected findings as there was 26.5%  
actual improvement vs. 25% expected improvement in clinical outcomes among the AIS  
patients undergoing endovascular revascularization procedures. There was no clearly  
reported baseline for the secondary outcomes since most of the performance measures  
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had not been previously reported prior to this project implementation. Based on the  
available documentation, these were the outcomes for nine AIS patients who had  
undergone endovascular revascularization in 2011: three patients died, six patients had no  
improvement after the endovascular procedure, and one patient had a major improvement  
and was discharged to the Extended Care Facility in a good condition. The following  
were the post-endovascular procedure complications in 2011: two patients developed  
hemorrhagic conversion of stroke, one patient had a myocardial infarction, one patient  
developed nosocomial pneumonia, and one patient developed pulmonary edema and  
respiratory failure as a result of exacerbation of diastolic heart failure (see Table 2). 
 Between November 1, 2012 and November 1, 2013 (study implementation period)  
eight patients with AIS had undergone endovascular revascularization treatment. One  
patient died (family withdrew care due to poor neurological prognosis), three patients had  
good functional outcome (mRs ≤2), four patients had little or no improvement, one  
patient had a complication of pneumonia and sepsis, and one patient had a complication  
of a small hemorrhagic conversion within the left cerebellar hemisphere. Table 3 
illustrates the data and clinical outcomes after the project implementation. 
Results 
Program Evaluation/Outcomes 
 Before this project implementation, “an action nurse” (ED or critical care float  
pool nurse) provided sedation under the supervision of the neurointerventionalist to AIS  
patients during endovascular revascularization procedures. According to the institutional  
protocol, most of these patients were intubated in the ED and pharmacologically  
paralyzed during the procedure for airway protection since the “action nurses” do not  
have the skills to intubate the patient in cases of airway compromise. There were  
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legitimate concerns regarding this practice expressed by radiology staff nurses as well as  
by the critical care float pool nurses themselves. Some of the action nurses had never  
previously participated in this type of procedure and felt uncomfortable managing the  
airway compromise and need for emergency intubation scenarios, hemodynamics of  
blood pressure (there are no clear guidelines available), cardiac issues (arrhythmias,  
ischemic changes on ECG), and potential serious procedure-related complications (intra- 
cranial hemorrhage, additional ischemic stroke, pulmonary edema, brain edema).  
 Moreover, before the project implementation there were few retrospective studies  
available that favored local anesthesia with light sedation over general anesthesia or  
heavy sedation for these procedures. These studies proclaim that patients who undergo  
endovascular revascularization treatment for AIS with use of light sedation have better  
clinical outcomes as opposed to patients managed with general anesthesia or heavy  
sedation. Although these studies have limitations (retrospective design and small sample  
size), if validated with prospective randomized trials, could have questioned in the future  
the utilization of the action nurses at the author’s institution due to mentioned previously  
nursing scope of practice and skills restrictions. 
 Moreover, the clinical outcomes among AIS patients treated with intra-arterial  
tPA and/or mechanical thrombectomy have been poor, especially when a high cost of the  
procedure is taken under consideration ($30,000-40,000). Among nine AIS patients, who  
had undergone endovascular treatment in 2011, only one patient showed improved  
clinical status. There were times, when the procedure had to be cancelled in those  
managed with a light/moderate sedation by an “action nurse” due to the patient’s  
agitation, worsening neurological status, cardiac or airway compromise with subsequent  
waste of already open supplies and time/cost of involved workforce (nurses, techs,  
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anesthesia, proceduralist).  
 There was an obvious need for change of this questionable clinical practice of  
utilizing “action nurses” for procedural sedation during endovascular revascularization  
therapy. The change in practice was initially proposed by the Interventional  
Neuroradiology NP at one of the facility’s stroke committee meetings. It was supported  
by the Stroke Program director and the rest of the committee. The Stroke Program  
Director issued an official letter to the hospital administration and the anesthesia  
department chair. At first, there was no response. Later, concerns about an insufficient  
anesthesia workforce were raised. Publishing a manuscript in the “Journal of Radiology  
Nursing,” which described this controversial clinical issue, and sharing a copy of this  
article with all involved stakeholders increased their level of engagement in this project.  
It also started a public discussion regarding the endovascular revascularization  
procedures logistics. The author, who published this manuscript received a positive  
responses from a nationwide interventional radiology community, as well as invitations  
for presentations and further publishing, even from anesthesiology journals. This project  
also helped to improve the process of stroke performance measures documentation at the  
author’s facility. Moreover, it motivated the project stakeholders to proceed towards  
obtaining a comprehensive stroke certification. The author and Neuroradiology NP  
played a significant role during this project implementation. She was the initiator of this  
idea and worked closely with both of her neurointerventionalists, who were very  
supportive and wanted this project to succeed.  
 Having anesthesia expertise and excellent collaboration among all stakeholders  
through their active participation in the Stroke Committee was the strength of this project.   
Its weakness was a lack of adequate anesthesia workforce at the author’s institution and  
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additional costs associated with the use of the anesthesiologists. Currently, AIS  
revascularization cases are considered a “neurologic emergency” at the University  
Hospita.l. As a result, anesthesia is readily available, even if an elective procedure has to  
be rescheduled/postponed. On the other hand, endovascular ischemic stroke procedures  
remain among the least common procedures that neurointerventionalists perform (nine   
procedures in 2011). Therefore, this number should not be too overwhelming to the 
anesthesia workforce at the author’s facility. As the number of endovascular  
revascularization procedures grows, it might necessitate opening of an additional  
anesthesia position. However, it should be financially justified by the savings this project  
could bring to the institution. Success of this project could help create new protocols for  
anesthesia management for AIS during endovascular revascularization procedures, not  
only at the author’s institution, but nationwide, and motivate researchers to conduct  
prospective, randomized studies on the efficacy of these costly ($30,000-40,000 per  
procedure) interventions (Appendix A, SWOT Analysis).  
 Despite a successful project implementation, there are still times when procedural  
sedation is provided by a critical care float pool nurses, if anesthesia is not immediately  
available. Most frequently, however, it applies to the inpatients who developed stroke  
symptoms while in the hospital due to different health problems. Therefore, the hospital  
staff directly involved in care of these patients is familiar with their past medical, surgical  
history, the time of stroke symptoms onset, and the patients’ fasting status. 
Discussion 
Summary 
 This project implementation changed a controversial clinical practice and  
provided the AIS patients at the author’s institution with the highest standards of care  
ACUTE ISCHEMIC STROKE                                                                                         32 
available based on current knowledge. It also helped to improve the clinical outcomes of  
the endovascular revascularization procedures for AIS by 26.5% within 1 year of the  
project implementation. Secondary gain of this project was an initiation of monitoring of  
the endovascular procedures outcomes and performance measures. Unfortunately, the  
project implementation had  not decreased the length of hospital stay among AIS patients  
as expected. The average length of hospital stay increased during the study period as  
compared to 2011 (16.75 days vs. 14.9 days, respectively). However, the mortality rate  
was higher in 2011, and three patients from the project group developed ischemic stroke  
as inpatients during their hospitalization due to different reasons (cardiac surgery, renal  
transplant and trauma patient), which could affect their length of hospital stay.  
 Shortage of the anesthesia workforce at the author’s facility and controversy  
about whether it is a “neurological emergency” were the main obstacles to this project  
implementation. Lack of adequate anesthesia force and associated time delays were  
additional constrains of this project. Having more research supporting intra-arterial tPA  
revascularization therapy and subsequent FDA approval would make this approach more  
convincing to all stakeholders worldwide. An additional anticipated threat to the project  
success was the patient population the author’s facility serves. A significant percentage of  
patients admitted to the University Hospital are low income, uninsured and/or homeless.  
This group of patients can be easily lost to follow up. Moreover, uninsured patients can  
create additional financial burdens for the institution and not participate in bringing in  
funds to cover additional anesthesia costs.  
 The driving force of this project was the explosion of studies analyzing 
mechanical thrombectomy devices that could be used beyond the 6-hr window. Intra- 
arterial tPA administration continues to be an off-label procedure due to lack of sufficient  
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scientific evidence supporting its use and it has to be delivered within 6 hours of  
symptoms onset. This makes an implementation of intra-arterial thrombolytic therapy  
more difficult.  
 The topic of this project is controversial and has never been analyzed from this  
point of view in the nursing or medical literature before. It is one of many healthcare  
practice issues that the author has questioned during her nursing career based on  
observations and experiences, in order to improve the standards of care and patient  
outcomes. The uniqueness of this project is its originality. While others have compared  
outcomes of AIS patients undergoing endovascular revascularization with sedation versus  
general anesthesia, no one had analyzed the differences in outcomes between two groups  
of patients; those managed by the anesthesia team versus those managed by the non- 
anesthesiologist team. Providing anesthesia management to a group of patients with a  
complex medical or unknown history, such as AIS patients, without being adequately  
skilled and familiar with Interventional Radiology, during an off-shift creates an ethical  
dilemma, and it is against the American Nurses Association Code of Ethics (Grace,  
2009). Implementation of this project hopefully helped nurses with their moral distress  
and increased the patients’ safety. 
 The author anticipates that publishing a manuscript on this topic will start a public  
discussion of this problematic clinical practice with the involvement of the other  
stakeholders and professional organizations that share the same concerns (e.g. American  
Heart Association). The author hopes that the positive changes this project brings will  
improve the AIS patients’ outcomes, decrease the length of hospital stay, and finally  
result in reduction of total healthcare costs. Beyond the financial objectives, this project  
could improve the outcomes of stroke patients, and increase their independence and 
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quality of life. The same changes could eventually be adopted by the other institutions  
nationwide, and perhaps worldwide. 
 The author believes that nurses who are educated and knowledgeable, and possess  
leadership skills, can increase collaboration with physicians and other healthcare  
providers to positively affect patients’ outcomes. Moreover, nurses, who share their  
knowledge by publishing their findings are given credit for it. This project is an example.  
Relation to Other Evidence 
 As mentioned previously, there are few retrospective studies (see Appendix D)  
that discuss the advantages and limitations of the anesthesia and sedation practices used  
for AIS patients during endovascular revascularization procedures. They attempt to  
convey that patients who undergo these procedures with general anesthesia, have  
worse clinical outcomes. However, the available evidence has its limitations such as  
retrospective design and small sample sizes, and should be analyzed with caution. There  
was a similar attempt undertaken in the past regarding patients undergoing elective  
carotid endarterectomy for carotid stenosis. While the initial retrospective studies favored 
local anesthesia, this was not validated with a prospective randomized trial, which  
showed no difference in outcomes between two groups of patients (Vaniyapong et al.,  
2013).  
Conclusions 
 There are but a few retrospective studies that attempt to show superiority of local  
anesthesia with conscious sedation as compared to general anesthesia during  
endovascular revascularization procedures among AIS patients. Until higher quality  
evidence is available, monitored anesthesia care with intravenous sedation or general  
anesthesia (both provided by the anesthesia team), depending on the clinical situation,  
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seems to be the safest  anesthesia management plan during endovascular procedures for  
AIS. The anesthesia team is best equipped to handle procedural complications, if they  
occur. In addition, in light of controversy surrounding endovascular revascularization  
procedures, it is imperative to provide optimal hemodynamic management and  
monitoring of these patients for possible complications such as reperfusion bleeding 
(Leifer et al., 2011). There are so many potential contributing factors (type of anesthesia  
being one of them) affecting the outcomes of these patients; however, if we control for  
some of them, we will be able to establish procedural logistics sooner. 
 Further prospective research studies are needed to determine what anesthesia  
management is optimal for patient safety and functional outcomes, and to create standard  
anesthesia/sedation protocols. Also, future prospective studies are desired to compare the  
outcomes between two groups of AIS patients; those who have been managed by the  
anesthesia team vs. those who have been managed by the non-anesthesiologist.  
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General Anesthesia 
Advantages: 
• Patient immobility 
• Perceived procedural safety with 
mechanical manipulation 
• Improved procedural efficacy 
• Better imaging (no motion artifact) 
• Optimal management of procedure-
related complications 
 
Limitations: 
• Time delay 
• Lack of adequate anesthesia workforce 
• Inability to monitor the patient’s 
neurological status  
• Higher risk of stroke as a result of 
hypotension during anesthesia 
induction 
• Higher risk of cardiovascular 
complications 
Sedation & local anesthesia 
Advantages: 
• Ability to start the procedure in a 
timely manner (“Time is brain”) 
• Ability to monitor the patient’s 
neurological status during the 
procedure and adjust the approach, if 
necessary 
• No risks of general anesthesia  
• Lower procedure costs 
 
Limitations: 
• Neurointerventionalist cannot fully 
concentrate on the procedure 
• Risk of aspiration and emergency 
intubation 
• Risk of not being able to control blood 
pressure adequately 
• Risk of not being able to manage 
cardiac complications adequately 
• Higher risk of aborting the procedure 
and costs associated with it 
• Patient factor: 
- Patient’s mobility 
- Non-English speaking 
- Hard of hearing 
- Severe anxiety, agitation 
- Aphasia, dementia 
- Not able to tolerate prolonged supine 
position (back pain, heart failure, etc.) 
- Inability to follow commands 
 
Table 1. Advantages and limitations of different anesthesia management modalities 
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Date Response to 
endovascular 
therapy 
Complications Outcome Length of 
Hospital Stay 
01/24/2011 Mercy retriever 
only. No 
recanalization. 
No improvement. 
No 
complications 
DC to SNF 
hemiplegic and 
aphasia 
10 days 
01/26/2011 Combined IV 
and IA tPA. 
Major 
improvement. 
No 
complications 
DC to SNF (but 
in very good 
shape) 
8 days 
02/24/2011 IA tPA and 
Mercy retriever, 
Unable to 
recanalize MCA. 
No improvement. 
NSTEMI 
Exacerbation of 
dHF 
Pulmonary 
edema 
Respiratory 
failure 
Hemorrhagic 
conversion 
DC to subacute 
care facility on a 
ventilator 
G-tube 
Tracheostomy 
35 days 
04/13/2011 IA tPA only. No 
improvement. 
No 
complications 
Died of massive 
stroke. Family 
withdrew care on 
04/25/2011 
12 days 
06/06/2011 IA tPA only. No 
improvement. 
No 
complications 
DC home. Died 
on 07/01/2011. 
21 days 
06/24/2011 Received 
bridging dose IV 
tPA and IA tPA 
plus Mercy 
retriever. No 
recanalization. 
No improvement. 
Nosocomial 
pneumonia 
Transferred to 
Kaiser with 
global aphasia 
and dense right 
hemiplegia. 
5 days 
09/26/2011 Mechanical 
thrombectomy 
only. No 
recanalization. 
No improvement. 
No 
complications 
Left hemiplegia, 
dysarthria 
18 days 
12/07/2011 Full dose IV tPA 
plus mechanical 
thrombectomy 
Hemorrhagic 
conversion  
Patient expired 
on 12/11/2011 
4 days 
11/09/2011 IV tPA plus 
mechanical 
thrombectomy. 
No 
recanalization. 
No improvement. 
No complication DC to SNF with 
global aphasia 
and G-tube. 
Regained right 
upper and lower 
extremity 
movement. 
21 days 
 
Table 2. Endovascular revascularization therapy for acute ischemic stroke at the 
University Hospital in 2011. 
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Date Response to 
Endovascular 
Therapy 
Complications Outcome Length of 
Hospital Stay 
11/05/2012 Mechanical 
thrombectomy with 
Trevo device 
Successful 
recanalization. 
None Full recovery. 
Neurologically 
intact. 
mRS≤ 1 
58 days 
11/15/2012 Mechanical 
thrombectomy with 
Trevo device with 
complete 
recanalization of 
Small 
hemorrhagic 
conversion 
within the left 
cerebellar 
DC to SNF. 
Oriented to self, 
ability to follow 
simple 
commands, 
14 days 
basilar artery.  hemisphere improved right 
hemiparesis. 
mRS= 3 
12/31/2012 Full dose of IV tPA 
plus mechanical 
thrombectomy with 
Trevo device. 
Technically 
successful 
recanalization of the 
basilar and right 
vertebral arteries. 
Large right 
cerebellar, 
occipital, and 
thalamic 
strokes. 
Family withdrew 
care due to poor 
neurological 
prognosis. 
Patient expired. 
mRS= 6 
3 days 
 
03/26/2013 IV tPA plus IA tPA 
administration (2 
mg). Partial 
recanalization of 
basilar artery.  
Pneumonia, 
sepsis 
Transferred to 
Kaiser. Able to 
withdraw 
extremities to 
pain; opens eyes 
to name and 
light 
mRS= 5 
2 days 
04/30/2013 IA tPA 
administration (2 
mg). No 
recanalization. 
No improvement. 
None Remained 
aphasic. 
mRS= 4 
18 days 
05/23/2013 IV tPA; no 
endovascular 
treatment. 
Recanalization of 
left ICA after IV 
tPA treatment 
None DC to SNF with 
right hemiplegia, 
dysarthria and 
dysphagia. G-
tube placement 
mRS= 5 
15 days 
05/24/2013 IA tPA (2 mg) plus 
mechanical 
thrombectomy with 
Trevo device. 
Recanalization of 
left MCA M1 
segment.  
None DC to assisted 
living facility 
with proximal 
right arm 
weakness; 
otherwise neuro 
exam WNL. 
mRS≤ 2 
10 days 
08/16/2013 IA tPA (2 mg) and 
mechanical 
thrombectomy with 
Trevo device. 
Recanalization of 
left MCA M1 
segment 
None Some expressive 
aphasia, but no 
other 
neurological 
deficits. 
mRS≤ 2 
14 days 
 
Table 4. Endovascular revascularization therapy for acute ischemic stroke at the 
University Hospital between November 1, 2012 and November 1, 2013. 
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Appendix A (SWOT Analysis) 
Strengths 
• Improved AIS patient outcomes 
• Higher quality of life among AIS 
patients (more independent, lower 
burden to the society) 
• Decreased length of hospital stay 
(lower costs due to shorter stay) 
• Rare procedures (not too 
Weaknesses 
• Lack of adequate anesthesia 
workforce 
• Additional costs due to anesthesia 
expenses 
• Lengthy endovascular procedures 
(4-5 hours) taking more anesthesia 
time 
  
 
 
 
 
 
 
overwhelming to anesthesia; 8-10 
procedures/year) 
• Having procedure protocol and 
structure could decrease the time 
from the patient admission to 
femoral puncture/revascularization 
• Not enough strong evidence 
supporting change 
• Rare procedures (hard to conduct 
randomized trials and not enough 
practice for NI) 
• Noninsured patients (additional 
expense to the institution) 
Opportunities 
• Justification for another anesthesia 
position opening 
• Good collaboration among 
stakeholders (practice for future 
projects) 
• Decreased length of hospital stay 
(more ICU beds available) 
• Creation of new anesthesia 
protocols nationwide/worldwide 
• Motivation for researchers to 
investigate this issue thoroughly 
with prospective studies (would 
provide better evidence about 
efficacy of the procedure) 
Threats 
• Delayed procedure start due to 
inadequate anesthesia workforce 
• Loss of patients to follow up (low 
income, homeless patient 
population) 
• Availability of stronger evidence 
could prove low efficacy of the 
procedure (risks outweigh the 
benefits) and demonstrate wasteful 
spending ($30,000-40,000 per 
procedure) 
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Appendix B (Proposed Budget) 
 
Cost of hospital services Cost of AIS 
revascularization 
procedure with 
anesthesia team  
Cost of AIS 
revascularization 
procedure with RN 
sedation  
 
Procedure cost per 
patient 
$30,000 $30,000 
Anesthesia cost per 
patient 
$7,300 $0.00 
Cost of nursing (action 
nurse & Radiology RN) 
per patient 
$700.00 $700.00 
Cost of stay in 
NeuroICU 
$17,000 x 1 day= 
$17,000 
$17,000 x 2days= 
$34,000 
($17,000/day/patient) 
Total cost of 
hospitalization per 
patient 
$55,000 $64,700 
Total cost of 
hospitalization x 9 
patients/year 
$495,000 $582,300 
Hospital savings per 
year 
 $87,300 
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Appendix C (GANTT chart) 
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Appendix D (JHNEBP Research Evidence Appraisal) 
 
Author 
(year) 
Study 
Design/Randomization/Sa
mple Size 
Study Conclusions Study Limitations Evidence 
Rating 
Abou-Chebl 
et al. (2010) 
Retrospective 
No randomization 
N= 980  
After the study results were adjusted 
for age, initial NIHSS score, time to 
femoral artery puncture, time to vessel  
opening, recanalization outcome, and 
intracerebral bleeding complication, 
patients placed under GA were at 
significantly higher risk of a poor 
outcome. Conscious sedation seemed 
to be as safe as GA with respect to the 
procedural complication of intracranial 
hemorrhage. 
Higher NIHSS scores on 
admission (17±5  
vs. 16±6, p<0.01) GA vs. 
conscious sedation group 
respectively. 
Not controlling for 
comorbidities, patient 
clinical status and 
endovascular techniques. 
The investigators did not 
address the  
issue of emergency 
intubation since they 
could not differentiate 
between the group of  
patients who were 
intubated before the 
procedure and those who 
were intubated  
emergently during the 
procedure. A clear 
definition of conscious 
sedation and who  
managed it was not 
provided in the study 
methodology.  
 
3C 
Jumaa et al. 
(2010) 
Retrospective 
No randomization 
N= 126 
The length of stay in the ICU was 
longer for the general anesthesia group 
(6.5 vs. 3.2 days, 
p=0.0008). The intraprocedural 
complications rate was lower among 
nonintubated patients as compared to 
the intubated group (6% vs. 15% 
respectively,  
p=0.13); however, the difference was 
not statistically significant. There were 
no significant discrepancies found in 
clinical outcomes and final infarct 
volumes on follow up imaging 
between the two anesthesia 
Small sample size. 
Difference in baseline 
NIHSS score (17.6 [14-
22] vs. 15.1 [12-18]) 
between two groups of 
patients (intubated state 
vs. non-intubated state, 
respectively).  
Missing data regarding 
time from decision to 
intervene to groin 
puncture, intra-procedural 
blood pressure variations 
and PCO2 values (acute 
3C 
management techniques. Regardless of 
the  
anesthesia management modality 
(intubated state vs. nonintubated state), 
all procedures in this study were 
performed with the involvement of an 
anesthesiologist.  
 
hypocapnia- 
vasodilation).   
McDonagh 
(2010) 
Retrospective survey  
No randomization 
N= 49/68 respondents (72% 
response rate) 
The most frequently used anesthesia 
type was general anesthesia, followed 
by conscious sedation (nurse 
administered), then monitored 
anesthesia care (MAC) administered 
by the anesthesia  
team, and finally local analgesia alone. 
Preference for GA was associated with 
a type of  
endovascular procedure. Mechanical 
thrombectomy was most frequently 
associated with  
a request for GA (55% of 
respondents). General anesthesia was a 
preferred practice for  
patients with a NIHSS score >15 (53% 
of respondents) and patients with 
brainstem stroke (51% of respondents). 
Small sample size. Recall 
bias (self-reported 
perceptions of 49 NI’s 
from the SVIN). Poor 
external validity (only 
SVIN members were 
surveyed). Missing data 
regarding the NI’s 
involvement in choosing 
anesthesia type, the 
ventilator/critical care 
management during the 
case, and specific criteria 
for requesting GA. 
3C 
Nichols et al. 
(2010) 
Retrospective 
No randomization 
N= 75 
Lower levels of sedation and male 
gender were correlated with good 
clinical outcome. The highest levels of 
sedation, including  
pharmacological paralysis, were the 
only independent predictors of death. 
Mild or no sedation, and no internal 
carotid artery occlusion were the 
predictors of successful  
reperfusion. The study found a 
significantly higher level of infection 
(pneumonia and/or  
sepsis) in patients who received heavy 
sedation (p= 0.02). High sedation level 
remained a predictor of poor clinical 
outcome and death even after baseline 
NIHSS score was accounted for in 
multivariable analysis. 
Small sample size. 
Baseline NIHSS score 
varied widely between 
the different levels of 
sedation (p= 0.03). The 
researchers were not able 
to precisely identify the 
types of  
anesthesia medications 
used, the duration of the 
treatment, the times of 
administration in  
relation to the 
angiographic procedure, 
and the route of 
administration. The 
authors did not specify 
who provided the 
anesthesia management 
during the procedure. 
  
3C 
Davis et al. 
(2012) 
Retrospective 
No randomization 
N= 96 
Mortality rate was higher in the 
general anesthesia group. After 
adjusting for baseline stroke severity, 
sedation and no incidence of 
Small sample size.  
No clear definition of 
baseline blood pressure 
value available. The 
3C 
hypotension (blood pressure ≤ 140 
mmHg) were predictors of a good 
functional outcome. The authors 
reported a good functional  
outcome in fifteen percent of patients 
managed with general anesthesia, as 
opposed to  
sixty percent of patients who were 
managed with sedation (p < 0.001). 
 
NIHSS score was higher 
in patients who received 
GA. 
Soize et al. 
(2012) 
Prospective, single center 
No randomization, no 
control group 
N= 36 (consecutive 
patients) 
The primary outcomes measured at 3-
months follow up were mortality rate 
and functional outcome. Twenty two 
patients (61.1%)  
presented at three months follow up 
with good functional outcomes and ten 
patients (27.8%) had a poor outcome 
or died. Successful revascularization 
was accomplished in twenty eight 
(77.8%) patients. The anesthesia team 
was used only in “severe cases,” the 
definition of which was not provided; 
whereas conscious sedation with IV 
midazolam was administered by the 
stroke neurologist.   
 
Small sample size. 
No control group, no 
randomization. 
High complication rate: 
3 C 
Li et al. 
(2013) 
Retrospective 
No randomization 
N= 109 
General anesthesia and post-procedural 
hyperglycemia (blood glucose > 200 
mg/dL) were the most important 
predictors of mortality (mortality rate 
40% vs. 22% when comparing general  
anesthesia vs. conscious sedation 
group, p= 0.045). The time from AIS 
symptoms onset to recanalization and 
the length of endovascular 
revascularization procedure were 
longer in the general anesthesia group. 
There were no statistically significant 
differences between general anesthesia 
and conscious sedation groups as far as 
procedure-related  
complications (p= 0.997) and the 
patients’ functional outcome at 
discharge (p= 0.631).  
 
Small sample size.  
Higher incidence of 
posterior circulation 
stroke among the GA 
group patients (20% vs. 
4% in CS group). Only 
patients treated with 
Merci retriever and 
Penumbra thrombectomy 
devices were included in 
this study (no cases with 
the latest generation of 
stent-retriever 
technology). Before 
2011, general anesthesia 
was used routinely for all 
patients undergoing 
endovascular treatment 
for AIS. 
Serial glucose levels 
could not be consistently 
collected retrospectively; 
therefore, definite 
conclusions cannot be 
made. Lack of long-term 
3C 
90-day clinical follow up. 
Absence of detailed 
information regarding 
stroke severity, size and 
location. 
 
